AbbVie (ABBV) stock Forecast for 2021 – 2025

AbbVie (ABBV) stock Forecast for 2022 – 2026

Last update: February 6, 2023 (22:51)

Sector: Healthcare

The share price of AbbVie Inc. (ABBV) now

What analysts predict: $162.84
52-week High/Low: $169.46 / $128.17

50/200 Day Moving Average: $158.46 / $149.5

This figure corresponds to the Average Price over the previous 50/200 days. For AbbVie stocks, the 50-day moving average is the resistance level today.

For AbbVie stocks, the 200-day moving average is the resistance level today.

Are you interested in AbbVie Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the AbbVie stock price in 2023, 2024, 2025, 2026, 2027. How much will one AbbVie share be worth in 2023 - 2027?

When should I take profit in AbbVie stock? When should I record a loss on AbbVie stock? What are analysts' forecasts for AbbVie stock? What is the future of AbbVie stock? We forecast AbbVie stock performance using neural networks based on historical data on AbbVie stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

AbbVie stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for AbbVie shares. This happens once a day.


Sell or Buy AbbVie (ABBV) stocks? Analytic Experts Forecasting...

AbbVie Stock Buy or Sell? ABBV Stocks Analytic Forecasts
February 6, 2023

We present you the most up-to-date and complete review of analytical trend forecasts and views on the ABBV stock market. … Read more



Historical and forecast chart of AbbVie stock

The chart below shows the historical price of AbbVie stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the AbbVie stock price can be found in the table below.

Long-term forecasts by years.

AbbVie daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 08 147.31 145.58 148.49 2.00
Feb 09 147.87 146.43 148.67 1.53
Feb 10 148.38 147.13 149.65 1.71
Feb 11 145.88 143.58 146.58 2.09
Feb 12 144.48 143.01 146.77 2.63
Feb 13 144.31 143.21 146.04 1.98
Feb 14 145.44 143.11 146.08 2.07
Feb 15 145.44 144.13 146.51 1.65
Feb 16 144.19 142.80 145.45 1.86
Feb 17 141.47 140.85 142.58 1.23
Feb 18 141.96 140.59 142.98 1.70
Feb 19 143.80 143.14 144.75 1.13
Feb 20 144.23 141.92 146.08 2.93
Feb 21 145.70 143.66 147.42 2.62
Feb 22 148.24 146.25 149.28 2.07
Feb 23 149.45 148.41 150.17 1.19
Feb 24 150.20 148.22 152.12 2.63
Feb 25 151.34 150.74 153.10 1.57
Feb 26 148.89 147.40 149.70 1.56
Feb 27 148.36 147.73 150.52 1.89
Feb 28 148.09 146.90 149.01 1.43
Mar 01 147.47 145.67 149.32 2.51
Mar 02 146.70 145.09 147.35 1.56
Mar 03 145.97 144.19 146.61 1.68
Mar 04 146.93 144.58 147.52 2.03
Mar 05 146.34 145.70 147.07 0.94
Mar 06 144.41 142.97 146.69 2.61
Mar 07 144.41 143.02 145.94 2.04
Mar 08 144.09 142.77 145.85 2.16
Mar 09 142.94 142.08 144.20 1.49

AbbVie Daily Price Targets


AbbVie Stock Forecast 02-08-2023.

Forecast target price for 02-08-2023: $147.31.
Positive dynamics for AbbVie shares will prevail with possible volatility of 1.964%.
Pessimistic target level: 145.58
Optimistic target level: 148.49

AbbVie Stock Forecast 02-09-2023.

Forecast target price for 02-09-2023: $147.87.
Positive dynamics for AbbVie shares will prevail with possible volatility of 1.511%.
Pessimistic target level: 146.43
Optimistic target level: 148.67

AbbVie Stock Forecast 02-10-2023.

Forecast target price for 02-10-2023: $148.38.
Positive dynamics for AbbVie shares will prevail with possible volatility of 1.686%.
Pessimistic target level: 147.13
Optimistic target level: 149.65

AbbVie Stock Forecast 02-11-2023.

Forecast target price for 02-11-2023: $145.88.
Negative dynamics for AbbVie shares will prevail with possible volatility of 2.050%.
Pessimistic target level: 143.58
Optimistic target level: 146.58

AbbVie Stock Forecast 02-12-2023.

Forecast target price for 02-12-2023: $144.48.
Negative dynamics for AbbVie shares will prevail with possible volatility of 2.559%.
Pessimistic target level: 143.01
Optimistic target level: 146.77

AbbVie Stock Forecast 02-13-2023.

Forecast target price for 02-13-2023: $144.31.
Negative dynamics for AbbVie shares will prevail with possible volatility of 1.937%.
Pessimistic target level: 143.21
Optimistic target level: 146.04

ABBV (ABBV) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Mar. 156.95 153.94 166.24 7.40
Apr. 161.47 154.63 166.90 7.35
May. 161.73 157.85 167.42 5.72
Jun. 164.84 161.80 170.51 5.10
Jul. 159.03 150.26 164.63 8.73
Aug. 163.74 158.63 166.75 4.87
Sep. 157.85 148.00 166.56 11.14
Oct. 163.28 153.61 166.28 7.62
Nov. 169.42 158.57 178.36 11.09
Dec. 173.62 166.53 177.92 6.40

AbbVie forecast for this year


AbbVie Stock Prediction for Mar 2023

An uptrend is forecast for this month with an optimal target price of $156.952. Pessimistic: $153.94. Optimistic: $166.24


AbbVie Stock Prediction for Apr 2023

An uptrend is forecast for this month with an optimal target price of $161.473. Pessimistic: $154.63. Optimistic: $166.90


AbbVie Stock Prediction for May 2023

An uptrend is forecast for this month with an optimal target price of $161.731. Pessimistic: $157.85. Optimistic: $167.42


AbbVie Stock Prediction for Jun 2023

An uptrend is forecast for this month with an optimal target price of $164.836. Pessimistic: $161.80. Optimistic: $170.51


AbbVie Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $159.034. Pessimistic: $150.26. Optimistic: $164.63


AbbVie Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $163.741. Pessimistic: $158.63. Optimistic: $166.75


AbbVie Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $157.847. Pessimistic: $148.00. Optimistic: $166.56


AbbVie Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $163.277. Pessimistic: $153.61. Optimistic: $166.28


AbbVie Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $169.416. Pessimistic: $158.57. Optimistic: $178.36


AbbVie Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $173.617. Pessimistic: $166.53. Optimistic: $177.92



AbbVie (ABBV) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 166.40 159.21 172.65 7.79
Feb 156.54 148.91 159.05 6.38
Mar 160.30 157.10 170.05 7.62
Apr 165.43 159.74 173.37 7.86
May 171.12 164.83 181.53 9.20
Jun 167.15 156.99 173.57 9.55
Jul 172.63 169.73 182.16 6.82
Aug 184.10 178.94 187.78 4.71
Sep 184.69 179.81 191.19 5.95
Oct 190.60 178.70 199.14 10.26
Nov 175.96 166.95 183.14 8.84
Dec 171.45 166.93 177.22 5.80

AbbVie (ABBV) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 172.28 165.94 176.41 5.94
Feb 171.31 163.64 176.66 7.37
Mar 177.07 174.09 181.04 3.83
Apr 175.09 164.86 179.15 7.98
May 173.54 170.77 182.01 6.18
Jun 179.10 173.80 190.42 8.73
Jul 175.66 165.12 185.36 10.92
Aug 169.34 160.67 179.50 10.49
Sep 161.61 153.60 165.23 7.04
Oct 165.62 159.92 171.98 7.01
Nov 165.89 159.78 175.97 9.20
Dec 170.40 163.99 173.53 5.50

AbbVie (ABBV) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 166.45 155.93 173.64 10.20
Feb 167.64 162.82 172.34 5.53
Mar 161.34 153.34 167.02 8.19
Apr 160.57 155.94 165.06 5.53
May 168.15 164.38 173.93 5.49
Jun 159.81 152.39 167.22 8.87
Jul 148.94 144.89 157.52 8.02
Aug 149.53 140.80 152.41 7.61
Sep 143.91 138.04 150.70 8.40
Oct 140.34 132.93 147.19 9.69
Nov 146.07 139.99 150.63 7.06
Dec 152.50 143.10 156.16 8.36

AbbVie (ABBV) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 159.21 154.49 163.66 5.60
Feb 154.88 151.53 158.47 4.38
Mar 156.73 149.09 161.00 7.40
Apr 154.98 147.79 163.53 9.63
May 166.38 160.79 170.78 5.85
Jun 171.04 167.21 180.21 7.21
Jul 165.71 160.01 174.99 8.56
Aug 171.14 163.20 178.40 8.52
Sep 170.32 163.24 181.22 9.92
Oct 168.82 160.72 178.28 9.85
Nov 174.49 166.68 178.26 6.50
Dec 176.17 169.12 184.63 8.40

AbbVie information and performance

AbbVie is a global, research and development, biopharmaceutical company that discovers, develops and markets biopharmaceutical and small molecule drugs. The company has proven experience in therapeutic areas such as immunology, oncology, neurobiology and virology, and it is in these areas that drug development is underway.

According to the results for the fourth quarter of 2016, the adjusted net profit amounted to 6.784 billion US dollars, in terms of operating indicators it increased by 6.9%. Adjusted 2016 net revenue of $ 25.560 billion, up 13.3% on an operating basis. The upward trend is also evident in adjusted earnings per share, at $ 4.82, reflecting an increase of 12.4%.

The company was founded by a spin-off from Abbott in 2013. But due to common roots and history, Abbott’s experience can be traced to AbbVie as well. Following the spin-off of the new firm in 2013, AbbVie immediately entered the prestigious Fortune 200 list.

Official site of the company

AbbVie Address

1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US

Market Capitalization: 257 579 106 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 29 801 001 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 19.42

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.279

Price/earnings to growth

DPS: 5.64

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0406

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 7.5

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.242
Quarterly Revenue Growth YOY: 0.033
Trailing PE: 19.42

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.39

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 6.04

Enterprise Value (EV) /Revenue

EV To EBITDA: 13.8

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1768480000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

AbbVie (ABBV) stock dividend

AbbVie last paid dividends on 01/12/2023. The next scheduled payment will be on 02/15/2023. The amount of dividends is $5.64 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.